bromocriptine ( cb-154 ) and the 8-alpha-ergoline cu 32-085 , two dopamine receptor agonists , were administered at different times to two series of 22 patients with parkinson 's disease , most of whom took levodopa ( plus benserazide ) at optimum dosage .
C0006230
bromocriptine
C0030567
parkinson 's disease